Trial Profile
A Study to Evaluate the Efficacy and Safety of Fasudil in Patients With Severe Pulmonary Hypertension With Right Heart Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Fasudil (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 28 Jun 2016 New trial record